Geneva Bioinformatics SA (GeneBio)'s Phenyx Chosen by British Columbia Proteomics Network
Published: Feb 21, 2008
A profound analysis was conducted at the BCPN to understand which tools users needed on their network; the addition of Phenyx was amongst the top requirements. After conducting an intensive evaluation, the BCPN discovered in Phenyx a very intuitive, dynamic and flexible tool generating excellent results. The addition of Phenyx complements the existing search tools on the network and further solidifies Phenyx as a key element to any high throughput proteomics project that allows life scientists, thanks notably to its powerful search algorithm, to produce identifications with a high degree of confidence.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio’s renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data, specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment while offering a flexible user experience and an adaptable architecture to help instil confidence in results assessment. (http://phenyx.vital-it.ch/pwi)
“We received many positive reviews of Phenyx from BCPN members, and after deeply analysing Phenyx results we believe it will greatly add to the existing platform so that we can continue to provide an excellent work environment for our members,” said Professor Christopher Overall, Canada Research Chair in Metalloproteinase Proteomics and Systems Biology at the Centre for Blood Research, University of British Columbia. “Our goal is to offer our network a high performance computing server that can handle the various demands and necessities inherent in a much-used proteomics cluster; we believe Phenyx fits nicely in this context and that the current agreement is only the first of, we hope, many in a long term collaboration with the GeneBio team.”
“The use of Phenyx by the BCPN is a great win for us and in line with our goals,” said Nasri Nahas, CEO of GeneBio. “Phenyx was designed for industrial use and massive scalability, and thus can accommodate both small and large cluster environments. Phenyx is already being utilized in numerous large-scale projects, like the HUPO Brain and Liver initiatives, amongst others; the addition of the BCPN is a testimony to the robustness and flexibility of this software. We look forward to our collaboration with the BCPN and to helping the BCPN improve and expand the reach of their formidable proteomics platform.”
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, we focus our expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community. For more information about GeneBio, please visit: www.genebio.com.
About The BC Proteomics Network
The BC Proteomics Network (BCPN) was created to leverage BC’s current proteomics resources, unify the province’s proteomics expertise and promote awareness of proteomics in the general life sciences community by administering a variety of programs including workshops, scientific symposia, training awards as well as communal infrastructure, research and analysis support, and collaborative research programs. For more information about the BCPN, please visit: www.bcpn.ca.
GeneBio contact: Mr. Andrew Smith Marketing Manager email@example.com Tel. +41.22.702.99.00
BCPN contact: Dr. Gregg Morin Head of Proteomics firstname.lastname@example.org Tel. +1 604-675-8154